К основному контенту

S&P 500 and Nasdaq start December at peak of optimism over vaccines

S&P 500 and Nasdaq begin December at peak of optimism over vaccines

(Reuters) - Indexes S&The P 500 and the Nasdaq hit record highs on Tuesday amid hopes that major pharmaceutical companies will begin shipping coronavirus vaccines by the end of the year, with better-than-expected data from China bolstered confidence in an early economic recovery..

Investors are closely following news of leading vaccine candidates and global shipments as pharmaceutical companies apply for regulatory approvals.

"Optimism continues to grow about the success of a given vaccine ... Global recovery is predicted next year," - told by Larry Adam of Raymond James.

By 19:00 Moscow time, the Dow Jones Index rose 1.19% to 29.991.55 points, the S index&The P 500 climbed 1.21% to 3.665.5 points, while the Nasdaq rose 0.91% to 12.309.23 points.

(Shriya Ramakrishnan and Medha Singh in Bangalore. Translated by Alexey Kuzmin. Edited by Anastasia Teterevleva)

Комментарии

Отправить комментарий

Популярные сообщения из этого блога

US stocks decline, but Dow Jones may see maximum monthly gain in 33 years

US stocks decline , but Dow Jones may see maximum monthly gain in 33 years American stock indices are showing a downward trend. Meanwhile, the Dow for November may show the best monthly result in 1987 amid optimism over news about COVID-19 vaccines and the prospect of new stimulus measures. The indicator is up almost 12.9% since the beginning of the month as of the close of the trading session on Friday.
1 комментарий
Далее...

Wall Street is down, vaccine in focus

Wall Street is down, vaccine in focus Investing.com - US equities open broadly lower on Monday, trailing after sharp gains in November. By 09:35 am ET (2:35 pm GMT), the Dow Jones Industrial Average fell 181 points, or 0.6%, to 29,730. S&The P 500 also fell 0.2% while the NASDAQ Composite rose 0.2%.. Slack (NYSE: WORK) shares hit another all-time high amid news last week of a possible merger with Salesforce (NYSE: CRM).
1 комментарий
Далее...

Gazprom discusses the sale of part of Gazprom Neft shares to the market

"Gazprom" discusses the sale of part of the shares "Gazprom Neft" to the market "Gazprom (MCX: GAZP)" discusses the possibility of selling shares "Gazprom Neft" on the market, CFO said "Gazprom Neft" Alexey Yankevich during the dialogue with investors organized by "VTB (MCX: VTBR) My investments". "I would like to "Gazprom Neft (MCX: SIBN)" entered the indices, but this requires 10% free float, now it has "Gazprom Neft" more than 5%.
Отправить комментарий
Далее...